A toolkit to address disparities in digitally enabled oncology trials By Ogkologos - September 5, 2025 432 0 Facebook Twitter Google+ Pinterest WhatsApp An initiative fosters inclusive research by improving patient access and participation in cancer research Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extending Indications for Pembrolizumab and Adopted a New Pharmaceutical Form Along with a New Route of Administration FDA Approves Pembrolizumab and Berahyaluronidase alfa-pmph for Subcutaneous Injection Study presents an AI-guided approach to target cancer antigens MOST POPULAR KRASG12D-Mutated NSCLC is Subtype with Distinct Co-mutations, a Colder Immune Microenvironment,... August 3, 2022 4 Steps We Can All Take on World Cancer Day to... February 3, 2023 10 Ways to Brave Cancer Treatment: Tips from a Survivor September 27, 2022 Targeted Drug Trio Improves Survival in Colorectal Cancer with BRAF Mutations November 13, 2019 Load more HOT NEWS Efficacy and Safety of Patritumab Deruxtecan in Patients with EGFR-mutated NSCLC... Physicians Debate Recent FDA Approval of an Immune Checkpoint Inhibitor in... ΚΑΡΚΙΝΟΣ ΤΟΥ ΜΑΣΤΟΥ Breast Cancer Vaccine Has Eliminated Cancer In Its First Human Patient
